Cargando…

Clinical Aspects of Gut Microbiota in Hepatocellular Carcinoma Management

Liver cancer, predominantly hepatocellular carcinoma (HCC), is the third leading cause of cancer-related deaths worldwide. Emerging data highlight the importance of gut homeostasis in the pathogenesis of HCC. Clinical and translational studies revealed the patterns of dysbiosis in HCC patients and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jinghang, Zhan, Qiao, Fan, Yanan, Lo, Emily Kwun Kwan, Zhang, Fangfei, Yu, Yanyan, El-Nezami, Hani, Zeng, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308793/ https://www.ncbi.nlm.nih.gov/pubmed/34206200 http://dx.doi.org/10.3390/pathogens10070782

Ejemplares similares

Theabrownin Alleviates Colorectal Tumorigenesis in Murine AOM/DSS Model via PI3K/Akt/mTOR Pathway Suppression and Gut Microbiota Modulation
por: Leung, Hoi Kit Matthew, et al.
Publicado: (2022)

The Emerging Role of Branched-Chain Amino Acids in Liver Diseases
por: Lo, Emily Kwun Kwan, et al.
Publicado: (2022)

Low dose of zearalenone elevated colon cancer cell growth through G protein-coupled estrogenic receptor
por: Lo, Emily Kwun Kwan, et al.
Publicado: (2021)

Human immune repertoire in hepatitis B virus infection
por: Zhan, Qiao, et al.
Publicado: (2021)

Regulation of T Helper 17 by Bacteria: An Approach for the Treatment of Hepatocellular Carcinoma
por: Sung, Cecilia Ying Ju, et al.
Publicado: (2012)

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
por: An, Ping, et al.
Publicado: (2018)

Research progress of gut microbiota in hepatocellular carcinoma
por: Li, Keliu, et al.
Publicado: (2022)

Editorial: Novel developments for promoting health through microbiota modulation
por: Gómez-Gallego, Carlos, et al.
Publicado: (2023)

Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
por: Xu, Jinghang, et al.
Publicado: (2020)

Mechanistic insights into zearalenone-accelerated colorectal cancer in mice using integrative multi-omics approaches
por: Lo, Emily Kwun Kwan, et al.
Publicado: (2023)

Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
por: Yu, Qiang, et al.
Publicado: (2020)

Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
por: Nath, Lekshmi R, et al.
Publicado: (2021)

Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?
por: Balan, Yuvaraj, et al.
Publicado: (2021)

Gut microbiota changes and biological mechanism in hepatocellular carcinoma after transarterial chemoembolization treatment
por: Bian, Chao-fan, et al.
Publicado: (2022)

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
por: Zheng, Ruipeng, et al.
Publicado: (2020)

Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
por: Jia, Wei, et al.
Publicado: (2020)

Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
por: Luo, Wenyu, et al.
Publicado: (2022)

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022)

Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma
por: Yoshikawa, Sayuri, et al.
Publicado: (2023)

Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion
por: Zhang, Ningning, et al.
Publicado: (2022)

Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling
por: Li, Zongjuan, et al.
Publicado: (2022)

Casual effects of gut microbiota on risk of infections: a two-sample Mendelian randomization study
por: Lyu, Beibei, et al.
Publicado: (2023)

Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
por: Liu, Qisha, et al.
Publicado: (2019)

Dysbiosis of Gut Microbiota Promotes Hepatocellular Carcinoma Progression by Regulating the Immune Response
por: Zhang, Nan, et al.
Publicado: (2021)

Chlorogenic Acid-Induced Gut Microbiota Improves Metabolic Endotoxemia
por: Ye, Xiaolin, et al.
Publicado: (2021)

Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma
por: Ni, Jiajia, et al.
Publicado: (2019)

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
por: Behary, Jason, et al.
Publicado: (2021)

Skin microbiota of oxazolone-induced contact hypersensitivity mouse model
por: Mäenpää, Kuunsäde, et al.
Publicado: (2022)

Operable hepatitis B virus-related hepatocellular carcinoma: gut microbiota profile of patients at different ages
por: Peng, Yu-Chong, et al.
Publicado: (2022)

Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis
por: Xin, Shengliang, et al.
Publicado: (2020)

Mechano-Signaling Aspects of Hepatocellular Carcinoma
por: Passi, Mehak, et al.
Publicado: (2021)

Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
por: Schneider, Kai Markus, et al.
Publicado: (2022)

Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma
por: Huo, Ran, et al.
Publicado: (2023)

Suppression of hepatocellular carcinoma by Ulva lactuca ulvan via gut microbiota and metabolite interactions
por: Qiu, Yinghui, et al.
Publicado: (2023)

The influence of gut microbiota on the rheological characterization of soy hull polysaccharide and mucin interactions
por: Yang, Lina, et al.
Publicado: (2020)

Interaction of Polyphenols as Antioxidant and Anti-Inflammatory Compounds in Brain–Liver–Gut Axis
por: Singh, Amritpal, et al.
Publicado: (2020)

Probiotics and atherosclerosis – a new challenge?
por: Kwan, Chan Yee, et al.
Publicado: (2012)

Interplay between Lignans and Gut Microbiota: Nutritional, Functional and Methodological Aspects
por: Baldi, Simone, et al.
Publicado: (2023)

Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD
por: Fernandez-Cantos, Maria Victoria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r7b121i97khnpat9r5hee472oj